Ani Pharmaceuticals (ANIP) Short-term Investments (2020 - 2026)

Ani Pharmaceuticals has disclosed Short-term Investments across 6 years of filings, most recently posting $36000.0 for Q1 2026.

• Short-term Investments for Q1 2026 came in at $36000.0, up 5.88% year-over-year; the trailing twelve-month figure through Mar 2026 was $36000.0 (up 5.88% YoY), and the FY2025 annual result was $36000.0, up 9.09% from the prior year.
• Short-term Investments came in at $36000.0 for Q1 2026 at Ani Pharmaceuticals, roughly flat from $36000.0 in the prior quarter.
• In the past five years, Short-term Investments ranged from a high of $5.0 million in Q4 2022 to a low of $33000.0 in Q4 2024.
• The 4-year median for Short-term Investments is $36000.0 (2025), against an average of $1.8 million.
• Across the five-year window, Short-term Investments climbed 0.1% in 2022 and gained 9.09% in 2025, its largest moves.
• Ani Pharmaceuticals' Short-term Investments stood at $5.0 million in 2022, then sank by 99.34% to $33000.0 in 2024, then climbed by 9.09% to $36000.0 in 2025, then changed by 0.0% to $36000.0 in 2026.
• The last three Short-term Investments figures came in at $36000.0 (Q1 2026), $36000.0 (Q4 2025), and $36000.0 (Q3 2025), per Business Quant data.